期刊文献+

脑卒中后康复训练对愈后的影响研究

After the apoplexy is restored to health the training to after influence research
原文传递
导出
摘要 目的:观察脑卒中后康复训练对愈后的影响的临床效果。方法:选择128例脑梗死病人随机分为观察组与对照组。对照组常规治疗,观察组除常规治疗外,给予康复训练程序、日常生活能力评分(ADL)训练。结果:观察组和对照组在神经功能缺损评分比较差异有显著性(P〈0.05),两组病人ADL比较无统计学意义(P〉0.05)。结论:早期康复治疗能促进脑功能重组,显著改善肢体运动功能及日常生活活动,减轻残疾程度,提高生存质量。 Objective:After the observation apoplexy is restored to health the training to the after influence clinical effect. Methods:Chooses 128 example brain stem dead patient to divide into the observation group and the control group stochastically. The con- trol group convention treatment, the observation group besides the conventional treatment, gives the recovery training procedure, the daily life ability grades the(ADL)training. Results: The observation group and the control group have the significance in the nerve function damage grading comparison difference(P〈0.05), two group of patient ADL compare the non--statistics significanee(P〉0. 05). Conclusion:The early recovery treatment can promote the brain function reorganization, obviously improves the body movement function and the daily life activity, reduces the disabled degree, improves the survival quality.
作者 刘晓娟
出处 《按摩与康复医学》 2011年第6期18-19,共2页 Chinese Manipulation and Rehabilitation Medicine
关键词 脑卒中 康复训练 影响 Under apoplexy Recovery training Influence
  • 相关文献

参考文献2

二级参考文献14

  • 1Hacke W, Kaste M, Bluhmki E, et al; ECASS Investigators. Thrombolysis with alteplase 3 to 4.5 hours after acute ischemic stroke. N Engl J Med, 2008, 359: 1317-1329.
  • 2Del Zoppo GJ, Saver JL, Jauch EC, et al; American Heart Association Stroke Council. Expansion of the time window for treatment of acute ischemic stroke with intravenous tissue plasminogen activator: a science advisory from the American Heart Association/American Stroke Association. Stroke, 2009, 40: 2945-2948.
  • 3The National Institute of Neurological Disorders and Stroke rt-PA Stroke Study Group. Tissue plasminogen activator for acute ischemic stroke. N Engl J Med, 1995, 333: 1581-1587.
  • 4Hacke W, Kaste M, Fieschi C, et al. Intravenous thrombolysis with recombinant tissue plasminogen activator for acute hemispheric stroke. The European Cooperative Acute Stroke Study (ECASS). JAMA, 1995, 274: 1017-1025.
  • 5Hacke W, Kaste M, Fieschi C, et al; Second European-Australasian Acute Stroke Study Investigators. Randomised double-blind placebocontrolled trial of thrombolytic therapy with intravenous alteplase in acute ischaemic stroke (ECASS Ⅱ). Lancet, 1998, 352: 1245-1251.
  • 6Clark WM, Wissman S, Albers GW, et al. Recombinant tissue-type plasminogen activator (Alteplase) for ischemic stroke 3 to 5 hours after symptom onset. The ATLANTIS Study: a randomized controlled trial. Alteplase Thrombolysis for Acute Noninterventional Therapy in Ischemic Stroke. JAMA, 1999, 282: 2019-2026.
  • 7Hickenbottom SL, Barsan WG. Acute ischemic stroke therapy. Neurol Clin, 2000, 18: 379-397.
  • 8Demchuk AM, Morgenstem LB, Krieger DW, et al. Serum glucose level and diabetes predict tissue plasminogen activator-related intracerebral hemorrhage in acute ischemic stroke. Stroke, 1999, 30: 34-39.
  • 9Kase CS, Furlan AJ, Wechsler LR, et al. Cerebral hemorrhage after intra-arterial thrombolysis for ischemic stroke: the PROACT Ⅱ trial. Neurology, 2001,57: 1603-1610.
  • 10Fiebach JB, Schellinger PD. MR mismatch is useful for patient selection for thrombolysis: yes. Stroke, 2009, 40: 2906-2907.

共引文献15754

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部